The molecular tumor burden index as a response evaluation criterion in breast cancer

Circulating tumor DNA (ctDNA) is a potential biomarker of prognosis and therapeutic response. We conducted this study to explore the role of the molecular tumor burden index (mTBI) in ctDNA as a therapeutic response and prognostic biomarker in a larger cohort prospective phase III randomized multice...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Zongbi, Ma, Fei, Rong, Guohua, Liu, Binliang, Guan, Yanfang, Li, Jin, Sun, Xiaoying, Wang, Wenna, Guan, Xiuwen, Mo, Hongnan, Wang, Jiani, Qian, Haili, Xu, Binghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260637/
https://www.ncbi.nlm.nih.gov/pubmed/34230452
http://dx.doi.org/10.1038/s41392-021-00662-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260637/
https://www.ncbi.nlm.nih.gov/pubmed/34230452
http://dx.doi.org/10.1038/s41392-021-00662-9

Ejemplares similares